To validate the characteristics of HXMM, A retina injury cell model induced by H2O2 was designed to simulate the retinal injury process occurring in AMD and DR, and bevacizumab was used as a positive control, as commonly used clinical anti-VEGF drug. This evidence concerns the gene VEGFA and age-related macular degeneration.